Welcome to the international HTA database

Showing [23368 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Guidelines for personal protective equipment. A rapid review comissioned by RACS
2020	National Institute for Health and Care Excellence (NICE)	Artificial iris insertion for congenital aniridia. NICE interventional procedures guidance 675
2020	NIHR Health Technology Assessment programme	Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in clinical immunology]
2020	Canary Health Service	[Transcranial magnetic stimulation for the treatment of cocaine addiction]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Niraparib (ovarian cancer) - Benefit assessment according to §35a Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention. NICE interventional procedures guidance 673
2020	NIHR Health Services and Delivery Research programme	Optimising acute care for people with dementia: a mixed-methods study
2020	Institute for Clinical and Economic Review (ICER)	Supervised injection facilities and other supervised consumption sites: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Relationship between volumes of services and quality of treatment outcome in the surgical treatment of breast cancer - rapid report]
2020	National Institute for Health and Care Excellence (NICE)	Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse. NICE interventional procedures guidance 669
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020	Canary Health Service	[Physical exercise intervention in older hospitalized patients for the prevention of functional and cognitive deterioration during hospital admission]
2020	Institute for Clinical and Economic Review (ICER)	Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ravulizumab (paroxysmal nocturnal haemoglobinuria) - Addendum to Commission A19-59]
2020	National Institute for Health and Care Excellence (NICE)	Cyanoacrylate glue occlusion for varicose veins. NICE interventional procedures guidance 670
2020	NIHR Health Technology Assessment programme	Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT
2020	NIHR Health Services and Delivery Research programme	Dementia and cognitive impairment in the older prison population of England and Wales: identifying individual need and developing a skilled, multi-agency workforce to deliver targeted and responsive services
2020	Canary Health Service	[Safety, clinical effectiveness and cost-effectiveness of interventions for the prevention of delirium in hospital admissions]
2020	Institute for Clinical and Economic Review (ICER)	Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dolutegravir/lamivudine (HIV infection) - Addendum to Commission A19-55]
2020	National Institute for Health and Care Excellence (NICE)	MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy. NICE interventional procedures guidance 671
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020	Canary Health Service	[Effectiveness, safety and cost-effectiveness of real-time continuous interstitial glucose monitoring systems (CGMS-RT) for Diabetes Mellitus type 1 and 2. Update]
2020	Institute for Clinical and Economic Review (ICER)	Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dolutegravir/lamivudine (HIV infection) - Second Addendum to Commission A19-55]
2020	National Institute for Health and Care Excellence (NICE)	Selective internal radiation therapy for unresectable colorectal metastases in the liver. NICE interventional procedures guidance 672
2020	NIHR Health Technology Assessment programme	Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Genetic testing in the context of familial hypercholesterolaemia management. Organisational and ethical implications (part 1), and economic aspects (part 2)
2020	Canary Health Service	[Safety, effectiveness, and cost-effectiveness of integrated continuous subcutaneous insulin infusion systems with continuous glucose monitoring sensor]
2020	Institute for Clinical and Economic Review (ICER)	Targeted immune modulators for ulcerative colitis: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ramucirumab (hepatocellular carcinoma) - Addendum to Commission A19-73]
2020	National Institute for Health and Care Excellence (NICE)	Fetoscopic prenatal repair for open neural tube defects in the fetus. NICE interventional procedures guidance 667
2020	Austrian Institute for Health Technology Assessment (AIHTA)	[Lung cancer screening in risk groups]
2020	Canary Health Service	[Cost-effectiveness analysis of newborn screening for severe combined immunodeficiency]
2020	Institute for Clinical and Economic Review (ICER)	Modulator treatments for cystic fibrosis: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dupilumab (atopic dermatitis in adolescents) - Addendum to Commission A19-75]
2020	National Institute for Health and Care Excellence (NICE)	Open prenatal repair for open neural tube defects in the fetus. NICE interventional procedures guidance 668
2020	NIHR Health Technology Assessment programme	High-dose oral vitamin D supplementation and mortality in people aged 65 84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation
2020	NIHR Health Services and Delivery Research programme	Access to primary and community health-care services for people 16 years and over with intellectual disabilities: a mapping and targeted systematic review
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Efficacy and safety of mechanical thrombectomy in the treatment of patients with ischaemic stroke beyond 6 hours after onset or with an unknown time of onset]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Lung cancer screening in risk groups: a review-update of the economic evidence (Part II)
2020	Institute for Clinical and Economic Review (ICER)	Alternative pricing models for remdesivir and other potential treatments for COVID-19
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor (combination with ivacaftor/tezacaftor, cystic fibrosis, 12 years and older, with F508del mutation, homozygous) - Addendum to Commission A19-70]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for natural history of COVID-19 in children
2020	National Institute for Health and Care Excellence (NICE)	Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues. NICE interventional procedures guidance 666
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020	Canary Health Service	[Radiofrequency ablation for metastatic spinal lesions]
2020	Institute for Clinical and Economic Review (ICER)	Acute treatments for migraine
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor (cystic fibrosis, 6 years and older, with G551D mutation) - Addendum to Commission A19-65]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for average length of stay in the intensive care unit for COVID-19
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor (combination with tezacaftor/ivacaftor, cystic fibrosis, 12 years and older, with F508del mutation, heterozygous) - Addendum to Commission A19-71]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for COVID-19 clinical samples
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: protecting health care workers' (HCW) families at home
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Andexanet alfa (acute major bleeding) - Addendum to Commission A19-76]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for asymptomatic transmission of COVID-19
2020	Ontario Health	Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[CD34+ cells (beta thalassaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Health Information and Quality Authority (HIQA)	Rapid health technology assessment of alternative diagnostic testing approaches for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2020	Ontario Health	Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mandibular advancement devices in mild to moderate obstructive sleep apnoea in adults]
2020	Health Information and Quality Authority (HIQA)	Evidence summary of placental transfer of antibodies
2020	Ontario Health	Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: corticosteroids for hospitalized patients
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Belimumab (SLE) - Benefit assessment according to §35a Social Code Book V]
2019	National Institute for Health and Care Excellence (NICE)	Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms. NICE interventional procedures guidance 658
2019	National Institute for Health and Care Excellence (NICE)	Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer. NICE interventional procedures guidance 659
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019	National Institute for Health and Care Excellence (NICE)	Transurethral laser ablation for recurrent non-muscle-invasive bladder cancer. NICE interventional procedures guidance 656
2019	National Institute for Health and Care Excellence (NICE)	Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids. NICE interventional procedures guidance 657
2019	National Institute for Health and Care Excellence (NICE)	Cardiac contractility modulation device implantation for heart failure. NICE interventional procedures guidance 655
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: The Argus II retinal implant]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cleft lip and palate: does using the nasoalveolar molding method before surgery lead to better results?]
2019	National Institute for Health and Care Excellence (NICE)	Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction. NICE interventional procedures guidance 653
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	HPV testing for primary cervical cancer screening: a health technology assessment
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cancer: can concomitant music therapy contribute to better treatment results?]
2019	National Institute for Health and Care Excellence (NICE)	Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia. NICE interventional procedures guidance 654
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: a health technology assessment
2019	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Rehabilitation for adults with traumatic brain injury]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[How do non-drug interventions influence coping with suicidal crises in unipolar depression?]
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI. NICE interventional procedures guidance 650
2019	NIHR Health Technology Assessment programme	Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Axicabtagene ciloleucel for large B-cell lymphoma: clinical report
2019	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Risk and needs assessment regarding reoffending in adolescents]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Idiopathic scoliosis: is video rasterstereography an adequate replacement for radiography in aftercare?]
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg. NICE interventional procedures guidance 651
2019	NIHR Health Technology Assessment programme	Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019	National Institute for Health and Care Excellence (NICE)	Bronchoscopic thermal vapour ablation for upper-lobe emphysema. NICE interventional procedures guidance 652
2019	National Institute for Health and Care Excellence (NICE)	Therapeutic hypothermia for acute ischaemic stroke. NICE interventional procedures guidance 647
2019	NIHR Health Technology Assessment programme	Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019	National Institute for Health and Care Excellence (NICE)	Collagen paste for closing an anal fistula. NICE interventional procedures guidance 648
2019	NIHR Health Technology Assessment programme	Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Effectiveness and safety of epicardial closure of left atrial appendage using clips by minimally invasive surgery for thromboembolism prevention in patients with atrial fibrillation]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Genome-wide sequencing: ethical considerations
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous mitral valve leaflet repair for mitral regurgitation. NICE interventional procedures guidance 649
2019	NIHR Health Technology Assessment programme	Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Validity, clinical utility and safety of the next-generation sequencing (NGS) genomic platform FoundationOne® in non-small cell lung cancer and other solid tumors]